Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

GLOBULIN, RHO (D) IMMUN

Closed
SPE2DP-26-T-4432Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

GLOBULIN RHO (D) IMMUNE, USP, 300 MICROGRAMS PER 1ML SYRINGE WITH SAFETY FEATURES, IS A PRESCRIPTION-ONLY INTRAMUSCULAR INJECTION INTENDED FOR ADULT USE, WITH A UNIT OF ISSUE OF EACH. THE PRODUCT MUST BE STORED AT 2 TO 8 DEGREES CELSIUS AND MUST NOT BE FROZEN. IT IS REGULATED BY THE FDA AND SUBJECT TO SPECIFIC PROCUREMENT REQUIREMENTS UNDER THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS, WITH THE RELEVANT REVISION CONTROLLING BASED ON SOLICITATION OR AWARD DATE DEPENDING ON ACQUISITION TYPE. THE ITEM IS CLASSIFIED AS A HAZARDOUS MATERIAL, REQUIRING A CURRENT MATERIAL SAFETY DATA SHEET (MSDS) TO BE SUBMITTED TO DLA.MSDS@DLA.MIL WITH THE COVER SHEET P-75 AND TO ACCOMPANY EACH SHIPMENT. PACKAGING MUST COMPLY WITH 49 CFR AND ICAO REGULATIONS FOR HAZARDOUS MATERIALS TRANSPORTATION. COVERAGE OF DEFENSE INFORMATION MAY APPLY, AND GOVERNMENT IDENTIFICATION MUST BE REMOVED FROM NON-ACCEPTED SUPPLIES. THE NSN IS 6505-01-417-1250, AND THE SOLICITATION NUMBER IS SPE2DP-26-T-4432, POSTED ON AUGUST 2, 2026, WITH A RESPONSE DEADLINE OF AUGUST 10, 2026. THE CONTRACTING AGENCY IS THE DEPARTMENT OF DEFENSE, MEDICAL SUPPLY CHAIN PHARM FSA, WITH DELIVERY REQUIRED WITHIN 20 DAYS OF AWARD TO FPO, 96691, AND POINT OF CONTACT IS JAMES FOGGIE AT JAMES.FOGGIE@DLA.MIL.

General Info

Globulin Rho(D) Immune, 300 mcg/mL, intramuscular, refrigerated 2-8°C, hazardous material, FDA-regulated, DLA procurement, NSN 6505-01-417-1250.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100119 BOX 1, FPO, AP, 96691, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4432 Medical Supply Chain Pharma

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA

Full Description

Show more
GLOBULIN,RHO (D) IMMUNE
GLOBULIN<(>,<)> RHO (D) IMMUNE, USP, 300 MCG, 1'S. 300 MICROGRAMS; ADULT
DOSE; DISPOSABLE; 1ML SYRINGE WITH SAFETY; INJECT ONLY INTRAMUSCULARLY;
UNIT OF ISSUE "EACH. STORE AT 2-8 DEG.C; DO NOT FREEZE; DISPENSE
BYPRESCRIPTION ONLY.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RQ034: HAZARDOUS COMMUNICATION STANDARD NOTICE
.
HAZARDOUS MATERIALS REQUIREMENTS.
.
MATERIAL SAFETY DATA SHEET (MSDS).
.
. A CURRENT MSDS SHALL BE PROVIDED FOR THIS
ITEM. DLA'S DOD HMIRS FOCAL POINT (VBA) HAS
ESTABLISHED AN ELECTRONIC MAILBOX TO WHICH
ONE CAN TRANSMIT THE MSDS, TOGETHER WITH THE
COVER SHEET (P-75) WHOSE CONTENTS ARE TO
REFLECT LOGISTICS INFORMATION PROPER TO THE
MSDS ASSOCIATED WITH THE AWARDED CONTRACT AND
NSN. THE ELECTRONIC MAILBOX ADDRESS IS
DLA.MSDS@DLA.MIL.
.
. IN ADDITION, A COPY OF THE MSDS SHALL
ACCOMPANY EACH SHIPMENT OF THIS ITEM.
.
PACKAGING.
.
. PACKAGING FOR HAZARDOUS MATERIALS SHALL
COMPLY WITH APPLICABLE REGULATIONS, I.E.,
49 CFR, INTERNATIONAL CIVIL AVIATION
ORGANIZATION (ICAO) TECHNICAL NSN/Part Number: 6505-01-417-1250 Quantity: 1 EA Purchase Request: 7017699524QTY: 1 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS